83.80
+0.80
+(0.96%)
At close: April 15 at 5:32:34 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 23 | 22 | 32 | 32 |
| Avg. Estimate | 4.57B | 4.78B | 19.13B | 21.1B |
| Low Estimate | 4.55B | 4.72B | 18.61B | 20.3B |
| High Estimate | 4.66B | 4.93B | 19.66B | 21.71B |
| Year Ago Sales | 3.86B | 4.12B | 16.75B | 19.13B |
| Sales Growth (year/est) | 18.58% | 16.13% | 14.26% | 10.27% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BSXC.VI | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 4/11/2025 |
| Reiterates | Needham: Hold to Hold | 3/3/2025 |
| Maintains | Stifel: Buy to Buy | 2/10/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/10/2025 |
| Maintains | UBS: Buy to Buy | 2/7/2025 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 2/6/2025 |